These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 32178737)

  • 1. Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury.
    Lin CF; Hsu KC; HuangFu WC; Lin TE; Huang HL; Pan SL
    BMC Pharmacol Toxicol; 2020 Mar; 21(1):21. PubMed ID: 32178737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of a Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model of Polycystic Liver Disease.
    Lorenzo Pisarello M; Masyuk TV; Gradilone SA; Masyuk AI; Ding JF; Lee PY; LaRusso NF
    Am J Pathol; 2018 Apr; 188(4):981-994. PubMed ID: 29366679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion.
    Aune SE; Herr DJ; Mani SK; Menick DR
    J Mol Cell Cardiol; 2014 Jul; 72():138-45. PubMed ID: 24632412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy.
    Xie M; Kong Y; Tan W; May H; Battiprolu PK; Pedrozo Z; Wang ZV; Morales C; Luo X; Cho G; Jiang N; Jessen ME; Warner JJ; Lavandero S; Gillette TG; Turer AT; Hill JA
    Circulation; 2014 Mar; 129(10):1139-51. PubMed ID: 24396039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes.
    Baumgardt SL; Fang J; Fu X; Liu Y; Xia Z; Zhao M; Chen L; Mishra R; Gunasekaran M; Saha P; Forbess JM; Bosnjak ZJ; Camara AKS; Kersten JR; Thorp EB; Kaushal S; Ge ZD
    Cardiovasc Res; 2024 Oct; 120(12):1456-1471. PubMed ID: 39001869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase 6 inhibitor ACY1215 offers a protective effect through the autophagy pathway in acute liver failure.
    Chen Q; Wang Y; Jiao FZ; Shi CX; Gong ZJ
    Life Sci; 2019 Dec; 238():116976. PubMed ID: 31634464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HDAC6 inhibitor ACY1215 inhibits the activation of NLRP3 inflammasome in acute liver failure by regulating the ATM/F-actin signalling pathway.
    Chen Q; Wang Y; Jiao F; Cao P; Shi C; Pei M; Wang L; Gong Z
    J Cell Mol Med; 2021 Aug; 25(15):7218-7228. PubMed ID: 34180140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infarct size-limiting effect of epoxyeicosatrienoic acid analog EET-B is mediated by hypoxia-inducible factor-1α via downregulation of prolyl hydroxylase 3.
    Neckář J; Hsu A; Hye Khan MA; Gross GJ; Nithipatikom K; Cyprová M; Benák D; Hlaváčková M; Sotáková-Kašparová D; Falck JR; Sedmera D; Kolář F; Imig JD
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1148-H1158. PubMed ID: 30074840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics.
    Laino AS; Betts BC; Veerapathran A; Dolgalev I; Sarnaik A; Quayle SN; Jones SS; Weber JS; Woods DM
    J Immunother Cancer; 2019 Feb; 7(1):33. PubMed ID: 30728070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC6-selective inhibitors decrease nerve-injury and inflammation-associated mechanical hypersensitivity in mice.
    Sakloth F; Manouras L; Avrampou K; Mitsi V; Serafini RA; Pryce KD; Cogliani V; Berton O; Jarpe M; Zachariou V
    Psychopharmacology (Berl); 2020 Jul; 237(7):2139-2149. PubMed ID: 32388618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC6 inhibitor ACY-1215 improves neuropathic pain and its comorbidities in rats of peripheral nerve injury by regulating neuroinflammation.
    Chen C; Liu A; Lu Q; Luo L; Li J; Ke J; Liu Y; Feng X
    Chem Biol Interact; 2022 Feb; 353():109803. PubMed ID: 34998817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hypoxia inducible factor-1α in remote limb ischemic preconditioning.
    Kalakech H; Tamareille S; Pons S; Godin-Ribuot D; Carmeliet P; Furber A; Martin V; Berdeaux A; Ghaleh B; Prunier F
    J Mol Cell Cardiol; 2013 Dec; 65():98-104. PubMed ID: 24140799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACY‑1215, a HDAC6 inhibitor, decreases the dexamethasone‑induced suppression of osteogenesis in MC3T3‑E1 cells.
    Wang N; Wang H; Chen J; Wang F; Wang S; Zhou Q; Ying J; Huang S; Wang P; Yuan F
    Mol Med Rep; 2020 Sep; 22(3):2451-2459. PubMed ID: 32705192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase 6 inhibitor ACY1215 ameliorates mitochondrial dynamic and function injury in hepatocytes by activating AMPK signaling pathway in acute liver failure mice.
    Chen Q; Wang Y; Jiao F; Shi C; Pei M; Wang L; Gong Z
    Histol Histopathol; 2020 Sep; 35(9):1047-1058. PubMed ID: 32572875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase 6 inhibition mitigates renal fibrosis by suppressing TGF-β and EGFR signaling pathways in obstructive nephropathy.
    Chen X; Yu C; Hou X; Li J; Li T; Qiu A; Liu N; Zhuang S
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1003-F1014. PubMed ID: 33103445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of myocardial injury by postconditioning: role of hypoxia inducible factor-1alpha.
    Zhao HX; Wang XL; Wang YH; Wu Y; Li XY; Lv XP; Zhao ZQ; Zhao RR; Liu HR
    Basic Res Cardiol; 2010 Jan; 105(1):109-18. PubMed ID: 19597757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The histone deacetylase inhibitor, Vorinostat, represses hypoxia inducible factor 1 alpha expression through translational inhibition.
    Hutt DM; Roth DM; Vignaud H; Cullin C; Bouchecareilh M
    PLoS One; 2014; 9(8):e106224. PubMed ID: 25166596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury.
    Yuan H; Li H; Yu P; Fan Q; Zhang X; Huang W; Shen J; Cui Y; Zhou W
    BMC Ophthalmol; 2018 Nov; 18(1):300. PubMed ID: 30453928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoform 6-selective histone deacetylase inhibition reduces lesion size and brain swelling following traumatic brain injury and hemorrhagic shock.
    Nikolian VC; Dennahy IS; Weykamp M; Williams AM; Bhatti UF; Eidy H; Ghandour MH; Chtraklin K; Li Y; Alam HB
    J Trauma Acute Care Surg; 2019 Feb; 86(2):232-239. PubMed ID: 30399139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.